Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 99

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 99
---
 listed on Nasdaq, Longevity may be unable to maintain the listing of its securities in the future.

| 35 |

If Longevity fails to meet the initial listing requirements and Nasdaq does not list its securities on its exchange, neither FutureTech nor Longevity would be required to consummate the Business Combination. In the event that FutureTech and Longevity elected to waive this condition, and the Business Combination was consummated without securities being listed on Nasdaq or on another national securities exchange, could face significant material adverse consequences, including:

| ● | a                                                                      
 limited availability of market quotations for FutureTech’s securities; |

| ● | reduced                                
 liquidity for FutureTech’s securities; |

| ● | a                                                                                        
 determination that FutureTech’s Common Stock is a “penny stock” which will               
 require brokers trading in FutureTech Common Stock to adhere to more stringent rules and 
 possibly result in a reduced level of                                                    
 trading activity in the secondary trading market for FutureTech’s securities;            |

| ● | a                                                
 limited amount of news and analyst coverage; and |

| ● | a                                                                                              
 decreased ability to issue additional securities or obtain additional financing in the future. |

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.”

If FutureTech’s securities were not listed on Nasdaq, such securities would not qualify as covered securities and we would be subject to regulation in each state in which we offer our securities because states are not preempted from regulating the sale of securities that are not covered securities.

Because the market price of shares of FutureTech Common Stock will fluctuate, Longevity stockholders cannot be sure of the value of the Business Combination consideration they will receive.

The market value of securities at the effective time of the Business Combination may vary significantly from their respective values on the date the Merger Agreement was executed or at other dates. Because the exchange ratio with respect to the shares of FutureTech Common Stock to be issued in the Business Combination is fixed and will not be adjusted to reflect any changes in the market value of shares of Class A Common Stock, the market value of the shares of FutureTech Common Stock issued in connection with the Business Combination may be higher or lower than the values of those shares on earlier dates, and may be higher or lower than the value used to determine the exchange ratio. Stock price changes may result from a variety of factors, including changes in the business,